A Brazilian scientific study, awarded the Capes de Tese Prize, investigates potential factors influencing the development and progression of Alzheimer's disease. This prize is one of Brazil's leading academic awards, annually recognizing outstanding postgraduate research.
The Grand Prize is awarded after selecting the three best dissertations in each major field of knowledge (Biological, Healthcare, and Agricultural Sciences; Exact, Technological, and Interdisciplinary Sciences; Humanities). The winners for this year were announced in April, and the award ceremony took place last Thursday (12) in Recife.
In the field of Biological, Healthcare, and Agricultural Sciences, the Grand Prize was given to a biochemistry doctoral thesis titled 'The Contribution of Glial, Genetic, and Vascular Factors to the Pathophysiology of Alzheimer's Disease in the Human Brain.' The author of this study is Juan Pedro Ferrari-Sousa from the Federal University of Rio Grande do Sul (UFRGS).
In his work, he investigated biological processes affecting the development and progression of Alzheimer's disease, including the interaction of nervous system cells, genetic factors, and health issues. It is estimated that 57 million people worldwide suffer from dementia, with Alzheimer's disease accounting for 60%–70% of these cases.
Causes of Alzheimer's Disease
The most common explanation for the disease involves the accumulation of proteins in the brain, specifically beta-amyloid and tau. In large quantities, they disrupt communication between neurons, leading to the gradual death of these cells and causing problems with memory, cognitive function, and speech.
However, this is only part of the picture. Juan Pedro Ferrari stated in an interview with Superinteressante that while these proteins are fundamental to the disease's development, more research shows that amyloid and tau accumulation cannot fully explain Alzheimer's progression, as people with similar characteristics and comparable protein loads can develop the disease very differently.
Consequently, various global studies are investigating other causes and factors influencing the onset and development of the disease, such as lifestyle and genetics. Ferrari-Sousa's study contributes to this discussion.
Evolution of the Disease
Ferrari-Sousa's work was inspired by his scientific advisor, neurobiologist Eduardo Zimmer, also from UFRGS. In a laboratory study funded by the Serrapilheira Institute, Zimmer discovered signs that astrocytes—brain cells that support neurons and aid brain function—influence the development of Alzheimer's disease and other neurodegenerative disorders.
In his doctoral dissertation, Juan Pedro studied individuals across aging and at different clinical stages of Alzheimer's disease to test whether this link with astrocytes could be found in humans. To do this, he performed brain scans and collected blood and cerebrospinal fluid samples (the clear fluid circulating in the central nervous system) for analysis.
Astrocytes were just one of the factors he investigated. The scientist also analyzed brain microglia—cells involved in the immune defense of the central nervous system and the regulation of inflammatory processes. Previous studies have shown that microglia can stimulate astrocyte reactions, so they were included in the research.
In addition to cells, Juan examined the connection between other biological processes and Alzheimer's disease, such as genetic predisposition and vascular risk factors (e.g., diabetes and hypertension). He observed that people with the APOEε4 genetic variation, already linked to an increased risk of Alzheimer's, also showed higher microglial activation in certain brain areas. APOEε4 also enhanced protein accumulation in the brain. In such cases, vascular risk factors can further accelerate neurodegeneration.
Eduardo Zimmer told Super that 'when microglia become reactive, they cause astrocytes to transform into immune-like cells. These two cells together trigger neuroinflammation.'
Thus, the study demonstrated that changes in astrocytes are associated with Alzheimer's disease, and that the interaction of these cells with microglia also appears to play an important role in the disease. Juan Pedro emphasized in a statement that 'it is not only the accumulation of Alzheimer's-related proteins that matters, but also how these cells respond to it.'
The researcher is currently continuing his study of Alzheimer's disease as a postdoctoral fellow at Harvard. Such research helps better understand the factors involved in a disease for which there is still no cure or treatment to halt its progression. The Brazilian study demonstrates that besides neurons and proteins, other brain cells require more attention in Alzheimer's research. This could be critically important for understanding the disease and developing more effective treatments.
While Ferrari-Sousa is pursuing his postdoc, Zimmer continues his research at the Serrapilheira Institute on astrocytes (neuron support cells) and their role in the process of brain neurodegeneration.



